期刊文献+

nm23-H1质粒和顺铂白蛋白联合治疗裸鼠移植瘤 被引量:2

Effect on Xenograft of Nude Mouse by Combination Therapy of nm23-H1 and Protein-cisplatin
暂未订购
导出
摘要 目的研究nm23-H1质粒和顺铂白蛋白联合应用对裸鼠移植瘤的影响。方法将15只BALB/C雌性裸鼠随机等量分为3组,即对照组、顺铂白蛋白组和顺铂白蛋白+nm23-H1质粒组。每只裸鼠均皮下注射浓度为每毫升 3.1×106个的舌鳞癌Tca8113细胞,2周后顺铂白蛋白+nm23-H1质粒组移植瘤瘤体内注射质粒-脂质体复合物,3d后顺铂白蛋白+nm23-H1质粒组和顺铂白蛋白组瘤体内注射顺铂白蛋白。观察裸鼠的重量、移植瘤体积和瘤体重量的变化。结果对照组裸鼠重量最轻。nm23-H1质粒和顺铂白蛋白联合治疗组肿瘤体积最小,瘤体重量最轻。结论 nm23-H1基因治疗和顺铂白蛋白联合可以明显抑制裸鼠移植瘤的生长。 Objective To study the effect of protein-eisplatin and nm23-H1 therapy on the tumor of nude mouse.Methods The 15 BALB/C female mice were divided into three groups, control group, protein-cisplatin group and protein-cisplatin+nm23-H1 plasmid group. Tca8113 were injected into the mice subcutaneously with the concentration of 3.1×10^6 cells/mL. After two weeks, the mixture of lipofectin and nm23-H1 was injected around xenograft of nude mouse. After three days, the protein-cisplatin was injected around xenograft. The weight of mouse, the volume and the weight of xenograft were measured. Results The weight of mouse was lightest in control group. The volume and weight of the transplanted tumor were lightest in nm23-H1 +protein-cisplatin group. Conclusion The combination therapy of nm23-H1 and protein-cisplatin can effectively inhibites the growth of xenograft in nude mouse.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2006年第2期170-172,共3页 West China Journal of Stomatology
基金 国家自然科学基金资助项目(39870746) 福建省自然科学基金重点资助项目(C0220002)
关键词 NM23-H1 顺铂 移植瘤 nm23-H1 cisplatin, xenograft
  • 相关文献

参考文献15

  • 1Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential[J].J Natl Cancer Inst, 1988, 80(3):200-204.
  • 2Kauffman EC, Robinson VL,Stedler WM, et al. Metastasis suppression: The evolving role of metastasis suppressor genes for regulating cancer ceil growth at the secondary site[J]. J Urol,2003, 169(3):1122-1133.
  • 3Iizuka N, Miyamoto K, Tangoku A, et al. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: Possible association with Na(+), K(+)-ATPase[J]. Br J Cancer, 2000, 83 (9):1209-1215.
  • 4Freije JM, Lawrence JA, Hollingshead MG, et al. Identification of compounds with preferential inhibitory activity against low-nm23-expressing human breast carcinoma and melanoma cell lines[J]. Nat Med,1997,3(4):395-401.
  • 5Leone A, Flatow U, King CR, et al. Reduced tumor incidence,metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells[J]. Cell, 1991, 65(1):25-35.
  • 6Suzuki E, Out T, Tsukuda K, et al. Nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation[J]. Int J Cancer, 2004, 108(2) :207-211.
  • 7Leone A, McBride OW, Weston A, et al.Somatic allelic deletion of nm23 in human cancer[J]. Cancer Res, 1991, 51(9):2490-2493.
  • 8Dusonchet L, Corsale S, Migliavacca M, et al. Nm23-H1 expression does not predict clinical survival in colorectal cancer patients[J]. Oncol Rep, 2003, 10(5) : 1257-1263.
  • 9Luo W, Matsuo K, Nagayama Y, et al.Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinoma: Lace of correlation between its expression and lymph node metastasis[J]. Thyroid, 1993, 3(2):105-109.
  • 10Holm R, Hoie J, Kaalhus O, et al. Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinoma of the thyroid gland[J]. Virchows Arch, 1995, 427(3): 289-294.

二级参考文献1

  • 1李宏卫,硕士学位论文,1996年

共引文献7

同被引文献30

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部